Therapeutic ERCP: the analysis of intra- and postoperative complications and long-term outcome

  • P.V. Ogorodnyk National Institute for Surgery and Transplantology by O.O. Shalimov, Kyiv
  • V.I. Kolomiytsev The Danylo Halytsky National Medical University in Lviv
  • A.G. Deynychenko National Institute for Surgery and Transplantology by O.O. Shalimov, Kyiv
  • B.F. Lischuk The Danylo Halytsky National Medical University in Lviv
Keywords: therapeutic ERCP, complications, outcome

Abstract

Aim. To study complications and outcome of therapeutic endoscopic retrograde pancreatocholangiography (ERCP) in patients with benign and malignant pathology of pancreatobiliary system. 

Material and Methods. During 15-year period, 20534 therapeutic ERCP were performed: sphincterotomy or/and balloon dilation of Vater's papilla (20534) with stone extraction (12680), lithotripsy (4384), endobiliary stenting (939), endoscopic papillectomy (41). 

Results and Discussion. 856 (4.17%) patients had complications after therapeutic ERCP: hemorrhage from place of sphincterotomy or ampullectomy - 441 (2.15%) patients, acute pancreatitis - 377 (1.84%), basket impaction - 37 (0.18%), perforation - 24 (0.12%), while 23 (0.11%) patients had several types of complications. Because of complications, 50 (0.24%) patients underwent surgery; total ERCP-related mortality was 0.058%. After ERCP, long-time follow-up revealed recurrent choledocholithiasis in 1127 (6.60% from patients with cholelithiasis), ascended cholangitis - 79 (0.38%), benign recurrent stenosis of Vater's papilla or of distal part of common bile duct - 109 (0.53%), benign stricture of bile ducts - 12 (0.06%). Causes, diagnostics, prevention, and management of these complications are discussed.

Conclusions. The main causes of complication of ERCP were found to be the following: incomplete investigation of patient or incorrect evaluation of his physiologic peculiarities, changes of Vater's papilla region or unwarranted unwary performing of endoscopic procedure. The application of minimally invasive treatment and medication had positive impact on most patients with ERCP adverse events.

References

Adler DG, Lieb II JG, Cohen J, Pike IM, Park WG, Rizk MK, Sawhney MS, Scheiman JM, Shaheen NJ, Sherman S, Wani S: Quality indicators for ERCP. Gastrointest Endosc 2015, 81(1), 54-66.

Alfieri S, Rosa F, Cina C, Tortorelli AP, Tringali A, Perri V, Costamagna G, Doglietto GB: Management of duodeno-pancreato-biliary perforations after ERCP: outcomes from an Italian tertiary referral center. Surg Endosc 2013, 27(6), 2005-2012.

Chathadi KV, Chandrasekhara V, Acosta RD, Decker GA, Early DS, Eloubeidi MA, Evans JA, Faulx AL, Fanelli RD, Fisher DA, Foley K, Fonkalsrud L, Hwang JH, Jue TL, Khashab MA, Lightdale JR, Muthusamy VR, Pasha SF, Saltzman JR, Sharaf R, Shaukat A, Shergill AK, Wang A, Cash BD, DeWitt JM: The role of ERCP in benign diseases of the biliary tract. Gastrointest Endosc 2015, 81(4), 795-803.

Cotton PB: ERCP (Ensuring Really Competent Practice): enough words-action please! Gastrointest Endosc 2015, 81(6), 1337-1342.

Dumonceau JM, Andriulli A, Elmunzer BG, Mariani A, Meister T, Deviere J, Marek T, Baron TH, Hassan C, Testoni PA, Kapral C: Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014. Endoscopy 2014, 46(9), 799-815.

Elmunzer BJ, Higgins PD, Saini SD, Scheiman JM, Parker RA, Chak A, Romanguolo J, Mosler P, Hayward RA, Elta GH, Korsnes SJ, Schmidt SE, Sherman S,Lehman GA, Fogel EL: Does rectal indomethacin eliminate the need for prophylactic pancreatic stent placement in patients undergoing high-risk ERCP? Post hoc efficacy and cost-benefit analyses using prospective clinical trial data. Am J Gastroenterol 2013, 108(3), 410-415.

Kang MH, Jeong JW, Han J-H: Successful hemostasis by using endoscopic band ligation for uncontrolled postendoscopic sphincterotomy bleeding. Gastrointest Endosc 2014, 79(2), 336-337.

Kim J, Lee SH, Paik WH, Song BJ, Hwang JH, Ryu JK, Kim Y-T, Yoon YB: Clinical outcomes of patients who experienced perforation associated with endoscopic retrograde cholangiopancreatography. Surg Endosc 2012, 26(11), 3293-3300.

Lee TH, Park SH: Optimal use of wire-assisted techniques and precut sphincterotomy. Clin Endosc 2016, 49(5), 467-474.

Nakai Y, Isayama H, Sasahira N, Kogure H, Sasaki T, Yamamoto N, Saito K, Umefune G, Akiyama D, Kawahata S, Matsukawa M, Saito T, Hamada T, Takahara N, Mizuno S, Miyabayashi K, Mohri D, Hirano K, Tada M, Koike K: Risk factors for post-ERCP pancreatitis in wire-guided cannulation for therapeutic biliary ERCP. Gastrointest Endosc 2015, 81(1), 119-126.

Matviychuk В.О., Kushniruk A.I., Kletsko I.Ya., Salo V.M., Tumak I.M. Complex prevention of acute pancreatitis after X-ray endoscopic transpapillary operations. Ukr J Surg 2013; 3(22): 84-89.

Nastashenko I.L. Transpapillary intervention in patients with non-neoplastic biliary obstraction. Surgery of Ukraine 2016; 2: 56-60.

Nychytaylo М.Yu., Grubnik V.V., Lurin I.A., Ogorodnik P.V., Slobodyanik V.P. Videoendoscopic diagnostics and minimally invasive surgery of choledocholithiasis. Кyiv.: VSI Medicina, 2013. - 296 p.

Published
2016-12-28
How to Cite
Ogorodnyk, P., Kolomiytsev, V., Deynychenko, A., & Lischuk , B. (2016). Therapeutic ERCP: the analysis of intra- and postoperative complications and long-term outcome. Acta Medica Leopoliensia, 22(4), 44-51. Retrieved from https://amljournal.com/index.php/journal/article/view/176